ROBINSON JAMES GEORGE purchased 0.3% of their position (9K shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $15.5K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 6/26/2019ACC: 0001651844-19-000015
Director
Since Oct 2018
+9K
Net shares
Net buyer
$15.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
9K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+7.40K
Price / share
$1.73
Trade value
$12.77K
% of position
0.2%
6/25/2019
3.43M→3.44M
Common Stock
Direct
Shares
+200.00
Price / share
$1.73
Trade value
$345.80
% of position
0.0%
6/25/2019
3.44M→3.44M
Common Stock
Direct
Shares
+1.40K
Price / share
$1.73
Trade value
$2.42K
% of position
0.0%
6/25/2019
3.44M→3.44M
Total
Net shares
+9K
Net value
$15.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2019 | P · Purchase | +7.40K | $1.73 | $12.77K | 0.2% | 3.43M | 3.44M |
| Common Stock Direct | 6/25/2019 | P · Purchase | +200.00 | $1.73 | $345.80 | 0.0% | 3.44M | 3.44M |
| Common Stock Direct | 6/25/2019 | P · Purchase | +1.40K | $1.73 | $2.42K | 0.0% | 3.44M | 3.44M |
| Total | +9K | $15.53K | ||||||
Derivative Transactions0
No derivative transactions reported